My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts

Axe Compute Inc. (AGPU) Dividend Safety Gauge & 10-Year DRIP Compounder

$7.61 -4.87% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $7.53

Axe Compute Inc. (AGPU) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • SELL / AVOID Cap $92.7M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on AGPU Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is AGPU stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Axe Compute Inc. (NASDAQ: AGPU) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $7.61 (-4.87% 1D, market cap $92.7M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 7/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 5/20. Across 1015 tracked Health Care issuers, AGPU ranks #427 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does AGPU compare to LAKE and CNXU in the Health Care sector?
▼

Within the Health Care sector (Industrial Specialties), AGPU carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, LAKE (Lakeland Industries Inc.) holds a E grade (26/100 RQD, P/E N/A, ROIC -9.5%, cap $87.3M) and CNXU (Conexeu Sciences Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $77.0M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for AGPU?
▼

Per AGPU's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001446159), Axe Compute Inc. generated $506.6M in revenue (+597178.7% YoY), -$233.1M in net income, and $0 in free cash flow against $52.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $7.53 (-1.07%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0.5% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.0% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D-
025507510042
3-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw E · Rk D+
Cash (7)Whales (7)SEC (10)Macro (13)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-7.2% Base Target
$14 Bull$7 Base$6 Bear
📬 FREE AGPU RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AGPU)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (42/100 Composite)
🔍 WHY AGPU SCORES 42/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+13/20 pts (31% of score)

FRED Regime × Technicals: 53% of 52W Range • RSI-14 at 40.8 (NEUTRAL RANGE)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (24% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 1/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
50
Grade C-$9.66-14.1% Next Q
Q2 (-2Q)
47
Grade D$8.30+8.2% Next Q
Q3 (-1Q)
45
Grade D$8.98-15.3% Next Q
Current
42
Grade D-$7.61-7% Hist 90D α
Trajectory: C- (50) → D- (42)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a AGPU Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While AGPU currently carries a cautious 42/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($10.36) and Max Pain ($7.99) forces dealer call-delta covering toward $14.16.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $AGPU• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “AGPU Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
CASH DIVIDEND + BUYBACK YIELD
1.8% Total Yield
0% Cash ($0.00/yr) + 1.8% Buybacks
PAYOUT SAFETY SPEEDOMETER
74/100 • REINVESTING IN GROWTH + BUYBACKS
FREE CASH FLOW PAYOUT RATIO
0% (100% Reinvested)
Retains cash flow for R&D and share repurchases
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (6.8% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $19,307

Est. Year-10 Shareholder Yield: $348/yr
$10.7K
Yr 1
$11.4K
Yr 2
$12.2K
Yr 3
$13.0K
Yr 4
$13.9K
Yr 5
$14.8K
Yr 6
$15.8K
Yr 7
$16.9K
Yr 8
$18.1K
Yr 9
$19.3K
Yr 10
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AGPU)

  • ✓Walkthrough of AGPU's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
AGPU // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +46.35%🛡️ HOLDING TREND SUPPORT
2026-11-03O $8.77H $8.77L $7.61C $7.61VOL 207.0K
RES: $15.48SUP: $7.49SMA50: $10.36SMA200: $6.63
$14.21$11.24$8.26$5.29$2.32RES $15.48SUP $7.49$7.612026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AGPU Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +597178.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on AGPU today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for AGPU. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for AGPU today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AGPU)

Health Care Rank #427 of 1015 ⚔️ LAKE vs AGPU Full Matrix →

1. Head-to-Head Health Care Peer Comparison (AGPU vs. LAKE, CNXU, NTRB, APT)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Axe Compute Inc. (AGPU) ranks #427 by composite RQD confidence (42/100, grade D-) and #665 by equity capitalization ($92.7M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with AGPU at 42/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
AGPU ACTIVE
Axe Compute Inc.
D- 42/100 — — -35.0% -4.87% $92.7M Benchmark Subject
LAKE
Lakeland Industries Inc.
E 26/100 — 32.9% -9.5% +1.82% $87.3M /lake-vs-agpu →
CNXU
Conexeu Sciences Inc.
D- 43/100 — — — -5.51% $77.0M /cnxu-vs-agpu →
NTRB
Nutriband Inc.
D- 37/100 — 27.8% -35.0% +1.75% $76.6M /ntrb-vs-agpu →
APT
Alpha Pro Tech Ltd.
C- 61/100 16.2x 38.1% 6.7% +2.22% $55.1M /apt-vs-agpu →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001446159 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Axe Compute Inc. (AGPU) reported GAAP revenue of $506.6M (+597178.7% vs. FY2024 revenue of $84.8K , and +1522.7% cumulative change since FY2023) , GAAP net income of -$233.1M, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, AGPU closed FY2025 with $52.9M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $506.6M -$233.1M — — $52.9M —
FY2024 (FY) 2024-12-31 $84.8K -$12.7M — — $5.0M —
FY2023 (FY) 2023-12-31 $31.2M -$14.0M -$13.2M -$13.2M — —

3. AGPU Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is AGPU stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Axe Compute Inc. (NASDAQ: AGPU) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $7.61 (-4.87% 1D, market cap $92.7M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 7/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 5/20. Across 1015 tracked Health Care issuers, AGPU ranks #427 in composite RQD confidence.

How does AGPU compare to LAKE and CNXU in the Health Care sector?

Within the Health Care sector (Industrial Specialties), AGPU carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, LAKE (Lakeland Industries Inc.) holds a E grade (26/100 RQD, P/E N/A, ROIC -9.5%, cap $87.3M) and CNXU (Conexeu Sciences Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $77.0M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for AGPU?

Per AGPU's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001446159), Axe Compute Inc. generated $506.6M in revenue (+597178.7% YoY), -$233.1M in net income, and $0 in free cash flow against $52.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is AGPU trading relative to its 50-day, 200-day, and 52-week technical levels?

AGPU last traded at $7.61 (-4.87% on volume of 118,074 shares), positioning the stock -26.54% below its 50-day simple moving average ($10.36) and +14.78% above its 200-day simple moving average ($6.63). Across its 52-week range of $1.03 to $13.49, AGPU sits at the 52.8% percentile with a 14-day RSI of 40.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($6.66 to $8.56).

ROARABLE RATING BRIEF • RQD 42/100 (D-) ✓ SEC XBRL & RQD VERIFIED

AGPU — Axe Compute Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Axe Compute Inc. (AGPU) earns a live Roarable RQD composite score of 42/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $7.61 (-4.87% 1D, market capitalization $92.7M).

  • Fundamental Cash Engine (7/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of —, operating margin of —, and free cash flow yield of —.
  • Whale 13F & Options Flow (7/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (13/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 1/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

. Is a NASDAQ-listed issuer in the Health Care sector and Industrial Specialties industry. Reported revenue in the SEC financials is — for FY 2025, $0.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Axe Compute Inc. (AGPU) reported $506.6M in annual revenue (up from $84.8K in FY2024, +597178.7% YoY) and -$233.1M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($31.2M revenue, -$14.0M net income) through FY2025, AGPU scaled operating cash flow to $0 and free cash flow to $0, backed by $52.9M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D- • RQD 42/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 7/20. With Fundamental Cash Engine at 7/20 and Institutional Whale Flow at 7/20, sustained execution supports upside toward the upper end of the $1.03 – $13.49 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

A prospective investor should watch whether the reported AI infrastructure contract values, which appear in news headlines, translate into revenue, since reported revenue remains near zero.

  • Key Question #1: Can AGPU sustain or expand its — operating margin and -35.0% ROIC against Industrial Specialties peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $506.6M and free cash flow of $0, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is AGPU's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

AGPU Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Axe Compute Inc. (AGPU) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to AGPU Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

AGPU Bull vs. Bear Conversation Board — What's Your Call at $7.61?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON AGPU 🐻 33% BEARISH CONVICTION
1. Pick Your Side on AGPU:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
QU QuantViper RQD DEBATE OPENER • Systematic Momentum Desk 🐂 BULLISH 🎯 Target: $10.24 (+28.0%)
📌 Pinned Debate

Recent headlines cite contracted customer AI infrastructure projects of more than $3.45 billion being brought toward production.

Picked up a starter position in AGPU in my $100K Virtual Cash book at $8.00. Recent headlines cite contracted customer AI infrastructure projects of more than $3.45 billion being brought toward production.. Trading inside a $1.49–$13.49 52-week range with 0.0% FCF yield gives solid downside support if Industrial Specialties multiples expand this quarter.

RetailWhale_TX 🐂 BULL

@CreditSpread_Watch Shorting a 7/20 institutional whale-flow stock at $8.00 is dangerous when funds are rotating into Health Care.

CR CreditSpread_Watch RQD DEBATE OPENER • Balance Sheet Analyst 🐻 BEARISH 🎯 Target: $6.64 (-17.0%)
Spot @ $8.00

Reported net loss widened to -$233.1M in FY 2025 with ROIC at -35% and FCF yield at 0%, while revenue stayed near $0.0M.

Fading this rally in AGPU at $8.00. Reported net loss widened to -$233.1M in FY 2025 with ROIC at -35% and FCF yield at 0%, while revenue stayed near $0.0M.. With a beta of 1.0 and the stock sitting at $8.00 (52-wk range $1.49–$13.49), the easy multiple expansion is already priced in.

LIVE TAPE